On June 20th, the Provincial Government Investment Fund Modern Pharmaceutical Industry Cluster Special Roadshow and Zhengzhou Airport Leading Industry Promotion Conference were held at the Henan Academy of Medical Sciences. EMICRO Biomedicine Company was invited by the conference to conduct an innovative drug project roadshow, which attracted the attention of many financial enterprises and investors.

　　Dr. Yang Yinke, Chief Medical Officer of EMICRO Biomedicine Company, stepped onto the stage as a roadshow guest. The innovative drug project of EMICRO Company, which he introduced, is currently undergoing a phase one clinical trial and has attracted attention for its unique efficacy, high drug efficacy, and broad market prospects. Dr. Yang is a Ph.D. from Boston University School of Medicine, a postdoctoral fellow at Harvard University, and a senior researcher. He has been engaged in biomedical research abroad for a long time and has rich practical experience. The road performance was colorful and successful, winning applause from more than 300 representatives and guests on site, and the project was well recommended.